{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:07:35Z","timestamp":1790809655759,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T00:00:00Z","timestamp":1612828800000},"content-version":"vor","delay-in-days":39,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001368","name":"V Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005737","name":"Universit\u00e9 Pierre et Marie Curie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 CA174713"],"award-info":[{"award-number":["RO1 CA174713"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cmghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.jcmgh.2021.02.004","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T13:48:14Z","timestamp":1613915294000},"page":"199-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Patient-Derived Mutant Forms of NFE2L2\/NRF2 Drive Aggressive Murine Hepatoblastomas"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2551-3243","authenticated-orcid":false,"given":"Huabo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan A.","family":"Mandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Schwalbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Gorka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brady","family":"Marburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarangarajan","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward V.","family":"Prochownik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmgh.2021.02.004_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MOP.0000000000000046","article-title":"Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy","volume":"26","author":"Czauderna","year":"2014","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3727\/105221616X693639","article-title":"Novel advances in understanding of molecular pathogenesis of hepatoblastoma: a Wnt\/beta-catenin perspective","volume":"17","author":"Bell","year":"2017","journal-title":"Gene Expr"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib3","doi-asserted-by":"crossref","first-page":"17524","DOI":"10.1074\/jbc.RA119.009979","article-title":"beta-Catenin mutations as determinants of hepatoblastoma phenotypes in mice","volume":"294","author":"Zhang","year":"2019","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib4","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1053\/j.gastro.2014.05.004","article-title":"Activation of beta-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice","volume":"147","author":"Tao","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature25480","article-title":"The landscape of genomic alterations across childhood cancers","volume":"555","author":"Grobner","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature25795","article-title":"Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours","volume":"555","author":"Ma","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/hep.28888","article-title":"Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups","volume":"65","author":"Sumazin","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib8","doi-asserted-by":"crossref","first-page":"12846","DOI":"10.1038\/s41598-018-31281-0","article-title":"A\u00a0catalogue of somatic NRF2 gain-of-function mutations in cancer","volume":"8","author":"Kerins","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib9","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1002\/cam4.2101","article-title":"Nrf2 in cancers: a double-edged sword","volume":"8","author":"Wu","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib10","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1146\/annurev-pharmtox-010818-021856","article-title":"Modulating NRF2 in disease: timing is everything","volume":"59","author":"Dodson","year":"2019","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1128\/MCB.26.1.221-229.2006","article-title":"Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1","volume":"26","author":"Kobayashi","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib12","doi-asserted-by":"crossref","first-page":"11908","DOI":"10.1073\/pnas.172398899","article-title":"Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants","volume":"99","author":"Dinkova-Kostova","year":"2002","journal-title":"Proc Natl Acad Sci U\u00a0S A"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib13","doi-asserted-by":"crossref","first-page":"7511","DOI":"10.1128\/MCB.00753-07","article-title":"Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response","volume":"27","author":"Tong","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1349-7006.2006.00352.x","article-title":"Increased susceptibility to hepatocarcinogenicity of Nrf2-deficient mice exposed to 2-amino-3-methylimidazo[4,5-f]quinoline","volume":"98","author":"Kitamura","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib15","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.1093\/nar\/gks409","article-title":"Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha","volume":"40","author":"Chorley","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib16","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.1093\/nar\/gkq212","article-title":"Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis","volume":"38","author":"Malhotra","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/10715761003667554","article-title":"Reactive oxygen species in cancer","volume":"44","author":"Liou","year":"2010","journal-title":"Free Radic Res"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib18","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/cdd.2014.16","article-title":"Oncogene-induced reactive oxygen species fuel hyperproliferation and DNA damage response activation","volume":"21","author":"Ogrunc","year":"2014","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib19","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1074\/jbc.M111.312694","article-title":"Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis","volume":"287","author":"Niture","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib20","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.freeradbiomed.2004.09.005","article-title":"Bcl-2 family proteins regulate mitochondrial reactive oxygen production and protect against oxidative stress","volume":"37","author":"Kowaltowski","year":"2004","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1148\/radiology.138.1.6256810","article-title":"The ultrasonographic appearance of cystic hepatoblastoma","volume":"138","author":"Miller","year":"1981","journal-title":"Radiology"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib22","doi-asserted-by":"crossref","first-page":"14740","DOI":"10.1074\/jbc.RA118.004099","article-title":"Myc and ChREBP transcription factors cooperatively regulate normal and neoplastic hepatocyte proliferation in mice","volume":"293","author":"Wang","year":"2018","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","article-title":"NRF2 and the hallmarks of cancer","volume":"34","author":"Rojo de la Vega","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib24","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1158\/1078-0432.CCR-09-3352","article-title":"Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features","volume":"16","author":"Solis","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib25","doi-asserted-by":"crossref","first-page":"26241","DOI":"10.1074\/jbc.M116.754218","article-title":"Coordinated activities of nultiple Myc-dependent and Myc-independent biosynthetic pathways in hepatoblastoma","volume":"291","author":"Wang","year":"2016","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5114\/ceh.2019.83153","article-title":"An updated review of cystic hepatic lesions","volume":"5","author":"Rawla","year":"2019","journal-title":"Clin Exp Hepatol"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib27","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib28","doi-asserted-by":"crossref","first-page":"e2226","DOI":"10.1038\/cddis.2016.132","article-title":"Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer","volume":"7","author":"Qu","year":"2016","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib29","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1158\/0008-5472.CAN-17-1325","article-title":"Genetic dissociation of glycolysis and the TCA cycle affects neither normal nor neoplastic proliferation","volume":"77","author":"Jackson","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib30","doi-asserted-by":"crossref","first-page":"13044","DOI":"10.1074\/jbc.M312846200","article-title":"Investigating mitochondrial redox potential with redox-sensitive green fluorescent protein indicators","volume":"279","author":"Hanson","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib31","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ccr.2008.11.002","article-title":"Hepatic stem-like phenotype and interplay of Wnt\/beta-catenin and Myc signaling in aggressive childhood liver cancer","volume":"14","author":"Cairo","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/hep.29672","article-title":"New insights into diagnosis and therapeutic options for proliferative hepatoblastoma","volume":"68","author":"Hooks","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib33","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib34","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3390\/cancers11081191","article-title":"Reactive oxygen species in the tumor microenvironment: an overview","volume":"11","author":"Weinberg","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib35","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jhep.2014.08.009","article-title":"The genomic landscape of hepatoblastoma and their progenies with HCC-like features","volume":"61","author":"Eichenmuller","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib36","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2016.03.014","article-title":"On the dependency of cellular protein levels on mRNA abundance","volume":"165","author":"Liu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib37","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.molmed.2017.03.004","article-title":"ROS in cancer: the burning question","volume":"23","author":"Chio","year":"2017","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib38","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1038\/onc.2008.79","article-title":"The role of Nrf2 in increased reactive oxygen species and DNA damage in prostate tumorigenesis","volume":"27","author":"Frohlich","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1023\/A:1025803600840","article-title":"Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer","volume":"6","author":"Sunamura","year":"2003","journal-title":"Angiogenesis"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib40","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrc1092","article-title":"Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma","volume":"3","author":"Hendrix","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037138","article-title":"In\u00a0vivo evolution of tumor-derived endothelial cells","volume":"7","author":"McGuire","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib42","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.semradonc.2004.04.001","article-title":"Oxidative stress, redox, and the tumor microenvironment","volume":"14","author":"Cook","year":"2004","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fendo.2018.00129","article-title":"The role for Myc in coordinating glycolysis, oxidative phosphorylation, glutaminolysis, and fatty acid metabolism in normal and neoplastic tissues","volume":"9","author":"Goetzman","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib44","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.critrevonc.2014.05.007","article-title":"Phosphofructokinase: a mediator of glycolytic flux in cancer progression","volume":"92","author":"Al Hasawi","year":"2014","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib45","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1158\/0008-5472.CAN-15-0876","article-title":"Plasminogen activator inhibitor-1 in cancer: rationale and insight for future therapeutic testing","volume":"75","author":"Placencio","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib46","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.imlet.2008.03.017","article-title":"The plasminogen activator inhibitor \"paradox\" in cancer","volume":"118","author":"Binder","year":"2008","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib47","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10555-019-09806-4","article-title":"The plasminogen activator inhibitor-1 paradox in cancer: a mechanistic understanding","volume":"38","author":"Kubala","year":"2019","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1677\/JME-06-0057","article-title":"Transgenic overexpression of plasminogen activator inhibitor-1 promotes the development of polycystic ovarian changes in female mice","volume":"39","author":"Devin","year":"2007","journal-title":"J\u00a0Mol Endocrinol"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib49","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijgo.2007.09.019","article-title":"Plasminogen activator and plasma activator inhibitor-1 in young women with polycystic ovary syndrome","volume":"100","author":"Lin","year":"2008","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jcmgh.2021.02.004_bib50","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s42003-018-0077-8","article-title":"PARP1 activation increases expression of modified tumor suppressors and pathways underlying development of aggressive hepatoblastoma","volume":"1","author":"Valanejad","year":"2018","journal-title":"Commun Biol"}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X21000370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X21000370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:27:34Z","timestamp":1762453654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X21000370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"alternative-id":["S2352345X21000370"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2021.02.004","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.09.13.295311","asserted-by":"object"}]},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-Derived Mutant Forms of NFE2L2\/NRF2 Drive Aggressive Murine Hepatoblastomas","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2021.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}